A four-week study found low-dose rapamycin improved brain blood flow in healthy middle-aged adults with the APOE4 Alzheimer's risk gene. The finding could point to ways to protect the brain before symptoms begin.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
An anti-aging drug may help protect the brain before Alzheimer's symptoms begin

Low-Dose Rapamycin Drug tested
Healthy Middle-Aged Adults Participants
Women Strongest benefit
4 Weeks treatment period